Pages

▼

Monday, October 1, 2018

FDA Approves New Treatment for Squamous Cell Carcinoma

... Breakthrough Therapy and Priority Review designations. Libtayo is produced by Regeneron Pharmaceuticals, based in Tarrytown, N.Y.
https://www.drugs.com/news/fda-approves-new-squamous-cell-carcinoma-77461.html?

No comments:

Post a Comment